Tag: immunotherapy
Allakos Announces New Antibody that Prevents Anaphylaxis in Humanized Mice
Company will initiate human trials next year.
Experimental Cat Allergy Shots Provide Longer-Lasting Relief
This approach might also be effective for other types of allergies, including food allergies.
Intrommune’s Toothpaste Immunotherapy for Peanut Allergy Completes Phase 1 Enrollment
Company is developing a patient-friendly treatment platform for peanut and other food allergies.
Private Law Firm to Investigate Claims on Behalf of Investors in...
It is unknown how this development will affect the ability of the company to eventually offer Viaskin Peanut as an FDA approved therapy.
ALK Starts Clinical Trial of SLIT Tablet to Treat Peanut Allergy
Sublingual Immunotherapy is administered via medications placed under the tongue.
DBV Announces Positive Topline Results from Phase 3 Trial of Viaskin...
Viaskin Peanut demonstrated a statistically significant treatment effect with 67.0% of subjects meeting the treatment responder criteria after 12 months.
Peanut Allergy Immunotherapy Toothpaste Makes Strides Toward Phase 2 Trial
Phase 1 study amended after two cohorts show no significant adverse events.
New Blood Test Simplifies the Diagnosis of Allergies and Can Help...
Test is painless, safe, reliable and scalable.
Study Finds Microneedle Delivery Successful in Test of Peanut Allergy Immunotherapy
Study finds five-minute weekly dose of peanut protein through the skin, delivered by a novel microneedle technology, was superior in desensitizing peanut-allergic mice compared to administering the protein through a skin patch.
Safety of Viaskin Peanut Patch Therapy Improved Over 3-Year Study
Reactions decreased over study duration.
